The EU AI in antibody discovery market is witnessing a significant surge, driven primarily by rising investments in biotechnology and a stronger focus on personalized medicine. Analysts foresee substantial advancements in clinical antibody development utilizing artificial intelligence, particularly within sectors like oncology and immunotherapeu… Read More